Literature DB >> 9620246

Number of potential patients to be treated with proton therapy in Italy.

R Orecchia1, M Krengli.   

Abstract

In radiotherapy, the use of proton beams is one of the most promising approaches in order to reduce the treatment volume and, consequently, increase the total dose avoiding severe complications to the normal tissues surrounding the target. Among the new hospital-based facilities that are planned for the next future, the italian project is in an advanced stage of study. Because of the complexity and high cost of the italian centre, one of the most important information in order to establish the cost/benefit balance, is represented by the number of potential patients to be treated for the various pathologies. For this reason it is useful to define a priority scale of clinical indications and, on this basis, to estimate the yearly patient afflux to the center, taking into account the incidence and the expected new cases to be treated with protons. Indications have been divided into two categories, according to decreasing priority. Category A includes all the tumors in which the use of proton therapy has clearly demonstrated to be advantageous, being the only way to give a curative dose to the target. In Italy, the estimated number of this category of patients is 825 each year. Category B comprises a great variety of tumors characterized mainly by a local evolution, with a limited likelihood of distant spread, and therefore potentially cured if the local control can be obtained. The total number of potential patients in this category is more than 10,000.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9620246     DOI: 10.1177/030089169808400218

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  4 in total

1.  ENLIGHT and other EU-funded projects in hadron therapy.

Authors:  M Dosanjh; B Jones; R Mayer; R Meyer
Journal:  Br J Radiol       Date:  2010-10       Impact factor: 3.039

2.  Proton therapy needs further technological development to fulfill the promise of becoming a superior treatment modality (compared to photon therapy).

Authors:  Daniel E Hyer; Xuanfeng Ding; Yi Rong
Journal:  J Appl Clin Med Phys       Date:  2021-11-03       Impact factor: 2.102

3.  Epidemiological study of the incidence of cancers eligible for proton or carbon ions therapy: methodology and results of recruitment estimation.

Authors:  Stéphanie Patin; Pascal Pommier; Hu Yi; Marie Hélène Baron; Jacques Balosso
Journal:  J Cancer Epidemiol       Date:  2013-06-20

4.  A Preliminary Study on the Estimation of the Number of Cancer Patients Eligible for Hadron Therapy in Iran and Fars Province.

Authors:  Mohammad Amin Hosseini; Mohammad Mohamadianpanah; Mohammad Zare-Bandeamiri; Mohammad Amin Mosleh-Shirazi
Journal:  Iran J Med Sci       Date:  2018-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.